Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteers

NCT04586803 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Gout
Hyperuricemia

Interventions

DRUG: SHR4640

Sponsor

Jiangsu HengRui Medicine Co., Ltd.